共 84 条
[1]
Eluwa GI(2012)Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria BMC Clin Pharmacol 12 7-1483
[2]
Badru T(2014)Risk and benefits of tenofovir in the context of kidney dysfunction in sub-Sarahan Africa CID 58 1481-201
[3]
Agu KA(2004)Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial JAMA 292 191-69
[4]
Akpoigbe KJ(2010)Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients J Acquir Immune Defic Syndr 53 62-660
[5]
Chabikuli O(2011)Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naive patients Scand J Infect Dis 43 656-1227
[6]
Hamelmann C(2012)Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort AIDS Res Ther 9 19-505
[7]
Estrella M(2010)Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215) AIDS Res Hum Retroviruses 26 1221-11
[8]
Moosa M(2011)Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients PLoS ONE 6 e22661-108
[9]
Nachega J(2010)Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients Clin Infect Dis 51 496-872
[10]
Gallant JE(2008)Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project Biomed Pharmacother 62 6-526